$NVAX Take your money to $BNTX Been telling you guys for 2 years that No-Vax/Nevervax/Novahoax is going nowhere. At least BNTX did just a tiny profit of: "The company, which partnered with Pfizer to develop the first Covid-19 vaccine approved for use in the U.S... "BioNTech's revenue surged 211% year over year to 6.4 billion euros ($6.7 billion), driven by sales of the company's COVID-19 vaccine. The German biotech shares the proceeds from the drug with its pharmaceutical partner Pfizer in most markets across the world. BioNTech's net profit, in turn, soared 228% to 3.7 billion euros ($3.9 billion), or roughly $15.04 per share. That was well above analysts' estimates, which had called for per-share profits of approximately $9.71." Compare that to: "Novavax NVAX, -7.05% said it earned $203 million, or $2.56 a share, in the quarter, swinging from a net loss of $223 million, or $3.05 a share, in the year-ago period." Chose wisely GL
4
3
3 Likes